The Norwegian Immunotherapy in Multiple Myeloma Study
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this observational study is to study the effectiveness and complications of novel immunotherapies used in the treatment of multiple myeloma in routine care in Norway. The aim is to close knowledge gaps, generate evidence for future clinical trials and contribute to future consensus on how to monitor for adverse events, and what mitigation strategies should be implemented, so that we can increase patient survival and quality-of-life.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Wcześniejsza diagnoza szpiczaka mnogiego, pierwotnej białaczki plazmocytowej lub amyloidozy AL
- •Planowane leczenie jednym z nowych leków immunoterapeutycznych: teclistamab, elranatamab, talquetamab, idecabtagene vicleucel lub ciltacabtagene autoleucel
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 20, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (23)
Sørlandet Hospital - Arendal
Arendal, Norway
Ålesund hospital, Department of hematology
Ålesund, Norway
Haukeland University Hospital
Bergen, Norway
Bodø Hospital
Bodø, Norway
Bærum Hospital
Bærum, Norway
Drammen hospital
Drammen, Norway
Førde hospital
Førde, Norway
Innlandet hospital trust
Gjøvik, Norway
Haugesund hospital
Haugesund, Norway
Sørlandet hospital
Kristiansand, Norway
Nordmøre and Romsdal Hospital - Kristiansund
Kristiansund, Norway
Levanger hospital
Levanger, Norway
Nordmøre and Romsdal Hospital - Molde
Molde, Norway
Akershus University Hospital (AHUS)
Nordbyhagen, Norway
Diakonhjemmet hospital
Oslo, Norway
Lovisenberg Diaconal Hospital
Oslo, Norway
Oslo Myeloma Center, Oslo University Hospital
Oslo, Norway
Telemark Hospital Trust
Skien, Norway
Stavanger University hospital
Stavanger, Norway
University hospital of North Norway
Tromsø, Norway
St. Olavs hospital HF
Trondheim, Norway
Vestfold Hospital Trust
Tønsberg, Norway
Volda hospital
Volda, Norway
Trial contact
Tobias S Slørdahl, MD PhD
Juni S Paulsen, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/21/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.